Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
NanoRepro AG: A reportable insider transaction was published on 27th March 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 27th March 2025,
The Insider Transaction was made by Stiller, Dr. Olaf 
. The transaction toke place on 25th March 2025. The order was executed at the trading place TRADEGATE. . The aggregated volume was 7,10 EUR, based on an average price of 1,42 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 26th March 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 26th March 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th March 2025. The order was executed at the trading place TRADEGATE. . The aggregated volume was 13.593,66 EUR, based on an average price of 1,42 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 26th March 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 26th March 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th March 2025. The order was executed at the trading place XETRA. . The aggregated volume was 15.771,00 EUR, based on an average price of 1,40 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th February 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th February 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 21st February 2025. The order was executed at the trading place XETRA. . The aggregated volume was 14.506,24 EUR, based on an average price of 1,28 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 17th February 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 17th February 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 13th February 2025. The order was executed at the trading place XETRA. . The aggregated volume was 18.750,00 EUR, based on an average price of 1,25 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 29th October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 29th October 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 28th October 2024. The order was executed at the trading place XETRA. . The aggregated volume was 17.300,00 EUR, based on an average price of 1,73 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 22nd October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 22nd October 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 21st October 2024. The order was executed at the trading place Tradegate. . The aggregated volume was 8.500,00 EUR, based on an average price of 1,79 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 22nd October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 22nd October 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 21st October 2024. The order was executed at the trading place XETRA. . The aggregated volume was 8.949,96 EUR, based on an average price of 1,79 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 21st October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 21st October 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 18th October 2024. The order was executed at the trading place XETRA. . The aggregated volume was 8.750,00 EUR, based on an average price of 1,75 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 21st October 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 21st October 2024,
The Insider Transaction was made by Stiller, Johanna . The transaction toke place on 18th October 2024. The order was executed at the trading place Tradegate. . The aggregated volume was 3.759,00 EUR, based on an average price of 1,79 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 30th August 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 30th August 2024,
The Insider Transaction was made by ASS GmbH . The transaction toke place on 29th August 2024. The order was executed at the trading place Tradegate. . The aggregated volume was 30.644,30 EUR, based on an average price of 1,94 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th July 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th July 2024. The order was executed at the trading place XETRA. . The aggregated volume was 3.279,18 EUR, based on an average price of 1,86 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th July 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th July 2024. The order was executed at the trading place XETRA. . The aggregated volume was 3.279,18 EUR, based on an average price of 1,86 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th July 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th July 2024. The order was executed at the trading place XETRA. . The aggregated volume was 3.279,18 EUR, based on an average price of 1,86 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th July 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th July 2024. The order was executed at the trading place XETRA. . The aggregated volume was 3.279,18 EUR, based on an average price of 1,86 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th July 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th July 2024. The order was executed at the trading place XETRA. . The aggregated volume was 3.279,18 EUR, based on an average price of 1,86 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th July 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th July 2024. The order was executed at the trading place XETRA. . The aggregated volume was 3.279,18 EUR, based on an average price of 1,86 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th July 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th July 2024. The order was executed at the trading place XETRA. . The aggregated volume was 3.279,18 EUR, based on an average price of 1,86 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th July 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th July 2024. The order was executed at the trading place XETRA. . The aggregated volume was 3.279,18 EUR, based on an average price of 1,86 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th July 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th July 2024. The order was executed at the trading place XETRA. . The aggregated volume was 3.279,18 EUR, based on an average price of 1,86 EUR. The nature of the Investment was Buy.
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Equity Story | 0 | - | - | EQS |
| Corporate Research | 0 | - | - | Corporate Research |
| Short Seller (DE) | 2 | 20th January 2022 | Voleon Capital Management LP | SSR (DE) |
| Short Seller (UK) | 1 | 20th January 2022 | Voleon Capital Management LP | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.